SQZ Biotechnologies Shares Outstanding 2020-2023 | SQZ
SQZ Biotechnologies shares outstanding from 2020 to 2023. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
SQZ Biotechnologies Annual Shares Outstanding
(Millions of Shares) |
| 2022 |
29 |
| 2021 |
28 |
| 2020 |
5 |
| 2019 |
2 |
SQZ Biotechnologies Quarterly Shares Outstanding
(Millions of Shares) |
| 2023-03-31 |
29 |
| 2022-12-31 |
29 |
| 2022-09-30 |
29 |
| 2022-06-30 |
28 |
| 2022-03-31 |
28 |
| 2021-12-31 |
28 |
| 2021-09-30 |
28 |
| 2021-06-30 |
28 |
| 2021-03-31 |
26 |
| 2020-12-31 |
5 |
| 2020-09-30 |
2 |
| 2020-06-30 |
2 |
| 2020-03-31 |
2 |
| 2019-12-31 |
|
| 2019-09-30 |
2 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$0.018B |
$0.021B |
|
SQZ Biotechnologies Company is a clinical-stage biotechnology company. It develops transformative cell therapies for patients with cancer, infectious diseases and other serious conditions. The company's prime product candidate consist SQZ-PBMC-HPV which is in clinical stage. SQZ Biotechnologies Company is based In Watertown, Massachusetts.
|
